Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Cancer Research|April 3, 2008
Blood vessel maturation and response to vascular-disrupting therapy in single vascular endothelial growth factor-A isoform-producing tumorsGillian M Tozer, Simon Akerman, Neil A Cross, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 14, 2016
Quantitative Estimation of Tissue Blood Flow RateGillian M Tozer, Vivien E Prise, Vincent J Cunningham
Methods in Molecular Biology (Clifton, N.J.)|March 24, 2009
Quantitative estimation of tissue blood flow rateGillian M Tozer, Vivien E Prise, Vincent J Cunningham
Cancer Gene Therapy|May 15, 2004
Analysis of the horseradish peroxidase/indole-3-acetic acid combination in a three-dimensional tumor modelJoanna Tupper, Olga Greco, Gillian M Tozer, et al.
Blood|October 16, 2012
The vitamin K-dependent anticoagulant factor, protein S, inhibits multiple VEGF-A-induced angiogenesis events in a Mer- and SHP2-dependent mannerSylvain Fraineau, Arnaud Monvoisin, Jonathan Clarhaut, et al.
International Journal of Cancer|September 28, 2002
Schedule dependence of combretastatin A4 phosphate in transplanted and spontaneous tumour modelsSally A Hill, David J Chaplin, Gemma Lewis, et al.
BMC Cancer|November 18, 2004
Direct visualization of electroporation-assisted in vivo gene delivery to tumors using intravital microscopy - spatial and time dependent distributionMaja Cemazar, Ian Wilson, Gabi U Dachs, et al.
Computer Methods and Programs in Biomedicine|August 10, 2010
CAIMAN: an online algorithm repository for Cancer Image AnalysisConstantino Carlos Reyes-Aldasoro, Michael K Griffiths, Deniz Savas, et al.
Biomedical Optics Express|October 31, 2017
Vascular patterning of subcutaneous mouse fibrosarcomas expressing individual VEGF isoforms can be differentiated using angiographic optical coherence tomographyRobert A Byers, Matthew Fisher, Nicola J Brown, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 28, 2009
Nitric oxide synthase inhibition enhances the tumor vascular-damaging effects of combretastatin a-4 3-o-phosphate at clinically relevant dosesGillian M Tozer, Vivien E Prise, Gemma Lewis, et al.
Pageof 7